DexCom, Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
8.8
Very Bullish
Overall
6.3
Neutral
Quality
Health
Growth
Valuation
Sentiment
DXCM
Consensus analyst target of $83.92 is 37% above current price.
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $83.92 (+36.8%)
24 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
DXCM
UNH
26.3×
Trailing P/E
27.9×
20.1×
Forward P/E
17.8×
19.3%
Profit Margin
2.7%
61.5%
Gross Margin
18.8%
35.6%
ROE
12.2%
15.0%
Revenue Growth
2.0%
91.9%
Earnings Growth
0.7%
—
Beta
0.41
—
Price / Book
—
$23.7B
Market Cap
$334.9B
$54 – $90
52-Week Range
$235 – $410
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →